State Street Corp Uni Qure N.V. Transaction History

State Street Corp

$2.41 Trillion
Q3 2024

A detailed history of State Street Corp transactions in Uni Qure N.V. stock. As of the latest transaction made, State Street Corp holds 174,902 shares of QURE stock, worth $996,941. This represents 0.0% of its overall portfolio holdings.

Number of Shares

174,902

Previous 176,302 0.79%

Holding current value

$996,941

Previous $789,000 9.25%

% of portfolio

0.0%

Previous 0.0%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$3.78 - $10.12 $5,292 - $14,167	-1,400 Reduced 0.79%	174,902 $862,000
Q2 2024 Aug 14, 2024	SELL	$4.39 - $5.43 $120,724 - $149,325	-27,500 Reduced 13.49%	176,302 $789,000
Q1 2024 May 15, 2024	SELL	$4.82 - $6.93 $15.8 Million - $22.7 Million	-3,275,070 Reduced 94.14%	203,802 $1.06 Million
Q4 2023 Feb 14, 2024	BUY	$5.63 - $8.27 $160,961 - $236,439	28,590 Added 0.83%	3,478,872 $23.6 Million
Q3 2023 Nov 14, 2023	BUY	$6.71 - $11.83 $6.1 Million - $10.7 Million	908,655 Added 35.75%	3,450,282 $23.2 Million
Q2 2023 Aug 14, 2023	SELL	$11.12 - $22.2 $3.3 Million - $6.58 Million	-296,385 Reduced 10.44%	2,541,627 $29.1 Million
Q1 2023 May 15, 2023	BUY	$18.7 - $23.07 $2.25 Million - $2.77 Million	120,136 Added 4.42%	2,838,012 $57.2 Million
Q4 2022 Feb 14, 2023	SELL	$18.12 - $27.32 $6.26 Million - $9.44 Million	-345,389 Reduced 11.28%	2,717,876 $61.6 Million
Q3 2022 Nov 15, 2022	BUY	$16.98 - $25.54 $11.9 Million - $17.8 Million	698,121 Added 29.52%	3,063,265 $57.5 Million
Q2 2022 Aug 15, 2022	SELL	$13.15 - $20.45 $5.89 Million - $9.17 Million	-448,272 Reduced 15.93%	2,365,144 $44.1 Million
Q1 2022 May 16, 2022	BUY	$14.54 - $21.5 $9.53 Million - $14.1 Million	655,732 Added 30.39%	2,813,416 $50.8 Million
Q4 2021 Feb 14, 2022	BUY	$20.24 - $36.01 $8.56 Million - $15.2 Million	423,019 Added 24.39%	2,157,684 $44.8 Million
Q3 2021 Nov 15, 2021	BUY	$26.01 - $38.22 $6.63 Million - $9.74 Million	254,847 Added 17.22%	1,734,665 $55.5 Million
Q2 2021 Aug 16, 2021	SELL	$29.97 - $37.17 $2.38 Million - $2.95 Million	-79,418 Reduced 5.09%	1,479,818 $45.6 Million
Q1 2021 May 17, 2021	BUY	$29.24 - $42.03 $13.7 Million - $19.6 Million	467,135 Added 42.77%	1,559,236 $52.5 Million
Q4 2020 Feb 16, 2021	BUY	$35.35 - $50.67 $34.7 Million - $49.7 Million	980,813 Added 881.33%	1,092,101 $39.5 Million
Q3 2020 Nov 10, 2020	SELL	$35.98 - $47.66 $176,517 - $233,819	-4,906 Reduced 4.22%	111,288 $4.1 Million
Q2 2020 Aug 14, 2020	BUY	$45.06 - $67.74 $619,890 - $931,899	13,757 Added 13.43%	116,194 $5.24 Million
Q1 2020 May 11, 2020	BUY	$40.01 - $73.97 $4.1 Million - $7.58 Million	102,437 New	102,437 $4.86 Million

Others Institutions Holding QURE

# of Institutions

153

Shares Held

41M

Call Options Held

925K

Put Options Held

617K

View Full List

About uniQure N.V.

Ticker QURE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 46,729,100
Market Cap $266M
Description
uniQure N.V., a gene therapy company, engages in the development of treatments for patients suffering from genetic and other devastating diseases. Its lead program is Etranacogene dezaparvovec (AMT-061), which is in Phase III HOPE-B pivotal trial for the treatment of hemophilia B. The company also engages in developing AMT-130, a gene therapy th...

More about QURE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of State Street Corp, based on Form 13F filings with the SEC.

News

Stay updated on State Street Corp with notifications on news.

Account

State Street Corp Uni Qure N.V. Transaction History